The presence of succinyl-coenzyme A: acetoacetate CoA-transferase (3-oxo acid-CoA transferase), an initiator of ketone body utilization in non-hepatic tissue was examined in a number of animal and human tumours of peripheral tissues. While enzyme levels in heart, kidney, lymphocytes and bladder were high, the tumours contained low or non-detectable levels of transferase activity, comparable with that of normal liver. The activities of acetoacetyl-CoA thiolase paralleled that of the transferase, except for the high activity in liver, and in all cases the tumour content of the enzyme was lower than that of the brain. The activity of 3-hydroxybutyrate dehydrogenase was similar in both normal and tumour tissue. The results indicate that tumours of non-hepatic tissues may be unable to metabolize ketone-bodies and suggest a therapeutic strategy for selective starvation of the tumour by dietary modification.
Hyperlipemia associated with mobilization of free fatty acids (FFA) from adipose tissue is a frequent companion of neoplastic diseases (Muller & Watkin, 1961) . In certain cases the increased mobilization of FFA is probably due to a lipolytic factor (toxohormone L) produced by the tumour tissue (Masuno et al., 1981) . Despite the hyperlipemia ketonuria is an uncommon phenomenon in cancer cachexia (Mider, 1951; Conyers et al., 1979) . In starved tumour-bearing animals ketonemia is less than in controls and the utilization of ketone bodies by peripheral tissues of tumour-bearing rats tends to be higher than in tissues from controls (Mider, 1951) .
Utilization of acetoacetate as an energy source requires the presence of two enzymes succinylcoenzyme A: acetoacetate CoA-transferase (3 oxo acid-CoA transferase) (EC 2.8.3.5 ) and 3 oxoacyl-CoA thiolase (EC 2.3.1.9). The former enzyme is essentially absent from normal liver, but is present in peripheral tissues in varying amounts (Fenselau & Wallis, 1974; Williamson et al., 1971) . In contrast to normal liver considerable amounts of 3-oxo acid CoA-transferase are present in neonatal liver and in hepatomas, with the increased activity correlating with an increased growth rate (Fenselau & Wallis, 1973; Fenselau et al., 1975) . Such an enzyme shift could provide a metabolic advantage for the tumour. The tumour content of the enzyme required for the conversion of 3-hydroxybutyrate to acetoacetate, 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30), however, has been found to decrease with increasing tumour growth rate, implying a possible limitation in tumour capacity for utilization of ketone bodies (Ohe et al., 1967) . The activity of 3-hydroxybutyrate dehydrogenase in renal tumours has been found to be considerably reduced in comparison with normal kidney whilst the levels of 3-oxo acid-CoA transferase and 3oxoacyl-CoA thiolase in renal tumours were similar to that found in kidney (Williamson et al., 1970) . However, astrocytomas, glioblastoma multiforme, Schwannomas and craniopharyngiomas have been shown to contain considerably reduced 3 oxo acid-CoA transferase activity when compared with normal brain (Fredericks & Ramsey, 1978) . The present study is designed to expand the knowledge on ketone body metabolism in tumour cells and reports the activities of 3 oxo acid-CoA transferase, acetoacetyl-CoA thiolase and 3-hydroxybutyrate dehydrogenase in a number of extra-hepatic animal and human tumours. (Lozzio & Lozzio, 1973) . L132, a normal human embryonic lung epithelial cell line was purchased from GIBCO Europe.
Materials and methods

Preparation of tissue extracts
Tissues from non-tumour bearing mice or tumours freed of connective tissue were quickly weighed, minced finely and transferred to a Potter-Elvehjem all glass homogenizer. Homogenization was carried out at 40C in 4 vol. of ice cold 0.25 M sucrose in 1 mM 2-mercaptoethanol, 10mM Tris-HCl buffer, pH 7.4. A portion of the homogenate cooled in icewater was exposed to ultrasonic vibration for 30 sec using an MSE sonic oscillator and 100 watts of power. The sonically treated homogenates were then centrifuged for 20 min at 30,000g. The supernatant fluid contained 100% of the 3-oxo acid CoA transferase activity, 77% of the acetoacetyl CoA thiolase activity and 200% of the 3hydroxybutyrate dehydrogenase activity. Enzyme activity is expressed in terms of soluble protein.
Determination of enzyme activities
The rate of acetoacetyl-CoA formation from succinyl-CoA and acetoacetate was determined spectrophotometrically at 313 nm using a millimolar extinction coefficient of 12 cm-I . The cuvettes contained 50mM Tris-HCl, pH 8.5, 5mM Mg Cl2, 5mM iodoacetamide (to inhibit acetoacetyl-CoA thiolase) 0.1 mM succinyl-CoA and enzyme sample (up to 200 MI for tumour tissue) in a final volume of 2 ml. The reaction was initiated by the addition of acetoacetate (100 imol) and the rate of increase in absorbance was measured at 250C for 2 min. The reaction rate was calculated from the linear portion of the absorption curve. For determination of the rate of succinyl-CoA formation the reaction mixture contained in a final volume of 2ml, 50mM Tris-HCl, pH 8.5, 10mM MgCl2, 5 mM iodoacetamide and 0.1 mM acetoacetyl-CoA at 250C. The change in absorbance at 303 nm was recorded for 2 min (spontaneous hydrolysis of acetoacetyl-CoA) and then the enzyme sample (up to 50 pl) was added and AE303 was recorded for a further 3 min. This represents spontaneous hydrolysis plus acetoacetyl-CoA deacylase activity. Sodium succinate (100,mol) was added and 303 was recorded for a further 3min, representing spontaneous hydrolysis plus deacylase plus 3-oxoacid CoA-transferase activity. The millimolar extinction coefficient of acetoacetyl-CoA was taken as 20.5 cm-1 under these conditions (Fenselau & Wallis, 1974) . The activity of acetoacetyl-CoA thiolase was determined by measuring the decrease in E303 due to cleavage of acetoacetyl-CoA (Stern et al., 1956) . The cuvettes contained 50mM Tris-HCl, pH 8.5, 5 mM MgCl2, 75 yM acetoacetyl-CoA, 100 pM CoA and 50mM KCI in a final volume of 2 ml. The reaction was initiated by the addition of the sample (5-50 pl) and the decrease in E303 was recorded for 2 min. The disappearance of acetoacetyl-CoA was considered to be mainly due to thiolase activity since the activities of interfering enzymes in extra-hepatic tissues have been reported to be negligible in comparison with that of the thiolase (McGarry & Foster, 1969) .
3-Hydroxybutyrate dehydrogenase activity was determined by the increase in absorption at 340 nm due to the formation of NADH . The reaction cuvette contained 16 mM Tris-HCI, pH 8.5, 0.32mM hydrazine hydrate (brought to pH 8.5 with INHCl) 16mM DL-3hydroxybutyrate and 0.45mM NAD in a total volume of 3ml. The reaction was initiated by the addition of the enzyme sample (50 or 100,pl) and the increase in E340 was recorded for 60min. The reaction rate was calculated from the linear part of the absorption curve (generally over the first 20min). Activity of all enzymes is expressed in pM of substrate utilized per minute per milligram of cell protein. The protein content of the sample was determined by Lowry's method using bovine serum albumin as a standard.
The concentration of 3-hydroxybutyrate in the experiment described in Table IV was determined by the increase in absorbance at 340nm due to the formation of NADH in the presence of 3hydroxybutyrate dehydrogenase as described by Williamson et al. (1962) .
Results
Activity of 3-hydroxybutyrate dehydrogenase in mouse tissues
The activity of 3-hydroxybutyrate dehydrogenase was of the same order of magnitude in both normal and tumour tissues examined (Table I) , suggesting that the level of this enzyme in tumours is sufficient to allow for utilization of 3-hydroxybutyrate by metabolic oxidation. Among the normal mouse tissues examined the level of 3-oxo acid-CoA transferase aetivity was highest in the heart and lowest in the liver, with the values for brain, lymphocytes and intestine falling between these values (Table II) . A similar distribution of enzyme activity has been reported in normal adult rat tissues (Mider, 1951 , Fenselau & Wallis, 1974 . Using these normal mouse tissues as a comparison, the level of the enzyme (measured in the direction of acetoacetyl-CoA formation) in tumours varied from 5% of the heart value in the M5076 murine reticulum cell sarcoma to 0.1% of the heart value in a human leukaemia cell line (K562). These results suggest that 3-oxo acid-CoA transferase activity is essentially absent from all of the murine and human tumour lines that were investigated. The loss of 3-oxo acid-CoA transferase in the tumours was not related to adaptation to tissue culture since there was no significant difference in enz6me activity between tumours passaged in animals and those maintained in vitro. Also the enzyme activity in a normal human epithelial foetal lung cell line growing a tissue culture was much higher than any of the tumour cell lines.
The activity of the enzyme measured in the direction of acetoacetate synthesis was about 9x higher than in the direction of acetoacetyl-CoA formation as has also been observed in rat tissues (Fenselau & Wallis 1974) . In comparison with normal bladder and lymphocytes the level of the enzyme in each of the tumours was more comparable with that of normal liver, i.e. enzyme activity was virtually absent. This suggests that acetoacetate may not be utilized as a metabolic substrate by tumours.
Activity of acetoacetyl-CoA thiolase in mouse tissues
The distribution of acetoacetyl-CoA thiolase in normal tissues was similar to that previously reported (Middleton, 1973) with high levels in heart and liver and somewhat lower levels in brain (Table  III) . In contrast the activity of the enzyme in all of the tumours was equal to or lower than that of brain. The presence of thiolase activity in liver and extrahepatic tumours in contrast with the absence of 3-oxo acid CoA-transferase probably reflects the role of the thiolase in processes other than ketonebody utilization (fatty acid oxidation and cholesterol synthesis). The activity of the thiolase in all tissues examined was much higher than that of the transferase, as previously reported (Fenselau & Wallis, 1974) .
Utilization of 3-hydroxybutyrate by tumour cells in vitro
The low levels of 3-oxo-acid CoA transferase in the concentration employed 3-hydroxybutyrate had no effect on the growth rate of the cell lines.
Discussion
Ketone-bodies serve as an important metabolic fuel for peripheral tissues during prolonged starvation. Utilization of 3-hydroxybutyrate and acetoacetate by the brain under such conditions reduces the requirement for glucose (Owen et al., 1967) . This leads to a decrease in gluconeogenesis from alanine and lactate in the liver, which is probably due to a decreased protein degradation in skeletal muscle. Infusion of ketone-bodies into humans results in a specific decline in plasma alanine comparable with that observed during starvation (Sherwin et al., 1975) . This suggests that ketone-bodies play a direct role in preventing protein catabolism during starvation, possibly due to their inhibitory action on branched-chain amino acid oxidation (Buse et al., 1972) . In addition ketone-bodies can inhibit lipolysis in adipose tissue either directly, or indirectly via stimulation of insulin secretion (Hawkins et al., 1971) , thus also reducing the availability of glycerol for gluconeogenesis.
The inability of any of the tumours or extrahepatic tissues investigated to utilize ketone-bodies suggests a therapeutic strategy for selective nutrient starvation of these tumours. Infusion of 3hydroxybutyrate into cancer patients on a low carbohydrate diet should counteract the breakdown of muscle and adipose tissue and act as an energy source for peripheral tissues reducing the requirement for glucose. Precursors for gluconeogenesis (other than lactate) would also be reduced. The tumour-induced lactate recycling may also be decreased by inhibiting phosphoenolpyruvate carboxykinase a key enzyme in gluconeogenesis (Gold, 1978) . Tumours, especially those exhibiting moderate to severe hypoxia might be expected to utilize glucose primarily as an energy source (Demetrakopoulos et al., 1978) and would also be unable to utilize the infused ketone-bodies. Tumour growth should therefore be inhibited by a shortage of essential metabolic fuels. Some support for this hypothesis comes from a study by Magee et al. (1979) who showed that D-3hydroxybutyrate caused a reversible, non toxic, inhibition of tumour cell growth in vitro, while dietary-induced ketosis reduced the number of B16 melanoma deposits in the lungs of C57BL/6 mice by two-thirds. Also Schaur et al. (1980) have shown that the continuous administration of physiological doses of the branched-chain amino acids leucine, isoleucine and valine to Yoshida sarcoma-bearing rats caused a, significant increase in survival time and a significant reduction in tumour size after 3 weeks of growth, as well as an increase in the synthesis of carcass proteins, while it left the proteolysis rate unchanged. The branched-chain amino acids and leucine in particular stimulate protein synthesis and inhibit protein degradation in muscle (Snell, 1980) . Infusion of keto-acids might be expected to have a greater effect in reducing tumour size, since unlike the branched chain amino acids they are not a source of fuel for gluconeogenesis.
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